Pfizer has officially ended its development of the experimental weight-loss pill, danuglipron, after a potential drug-induced liver injury was reported during a clinical trial. This decision comes as ...

I’m Kelly Grant, a health reporter with The Globe and Mail. Yesterday, the Canadian Medical Association Journal published the first new guideline on the treatment of childhood obesity in nearly 20 ...

Eli Lilly's Mounjaro enters Indian market, triggering a sharp rise in consultations as obesity rates climb and patients seek more accessible treatment options ...

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike GLP-1 drugs, which are administered via injection and ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...